Paper36938543
Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression.
Bryant JD and 8 others. Mol Ther Oncolytics, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression. Papers, record 36938543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36938543
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18773930 | Cis-active RNA elements (CREs) and picornavirus RNA replication. | Virus Res | 2009 | https://conductscience.org/library/papers/18773930 | PubMed |
| 2 | 10500216 | A coding RNA sequence acts as a replication signal in cardioviruses. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10500216 | PubMed |
| 3 | 19671871 | MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19671871 | PubMed |
| 4 | 26462293 | Designing Herpes Viruses as Oncolytics. | Mol Ther Oncolytics | 2015 | https://conductscience.org/library/papers/26462293 | PubMed |
| 5 | 31273010 | Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31273010 | PubMed |
| 6 | 21507242 | TurboFold: iterative probabilistic estimation of secondary structures for multiple RNA sequences. | BMC Bioinformatics | 2011 | https://conductscience.org/library/papers/21507242 | PubMed |
| 7 | 8073288 | Engineering poliovirus as a vaccine vector for the expression of diverse antigens. | Science | 1994 | https://conductscience.org/library/papers/8073288 | PubMed |
| 8 | 8615042 | Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice. | Virology | 1996 | https://conductscience.org/library/papers/8615042 | PubMed |
| 9 | 30209219 | Homologous recombination is an intrinsic defense against antiviral RNA interference. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30209219 | PubMed |
| 10 | 34464163 | Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/34464163 | PubMed |
| 11 | 22971818 | Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001. | J Gen Virol | 2012 | https://conductscience.org/library/papers/22971818 | PubMed |
| 12 | 9420196 | Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames. | J Virol | 1998 | https://conductscience.org/library/papers/9420196 | PubMed |
| 13 | 7889939 | Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. | EMBO J | 1995 | https://conductscience.org/library/papers/7889939 | PubMed |
| 14 | 26014293 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26014293 | PubMed |
| 15 | 11483761 | Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. | J Virol | 2001 | https://conductscience.org/library/papers/11483761 | PubMed |
| 16 | 29702686 | Multiple poliovirus-induced organelles suggested by comparison of spatiotemporal dynamics of membranous structures and phosphoinositides. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/29702686 | PubMed |
| 17 | 10933703 | Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice. | J Virol | 2000 | https://conductscience.org/library/papers/10933703 | PubMed |
| 18 | 7707546 | Theiler's virus as a vector for foreign gene delivery. | J Virol | 1995 | https://conductscience.org/library/papers/7707546 | PubMed |
| 19 | 27078068 | RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence. | Cell Host Microbe | 2016 | https://conductscience.org/library/papers/27078068 | PubMed |
| 20 | 26311731 | A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26311731 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41916730 | Dual-chemokine-armed oncolytic Senecavirus A co-recruits cDC1 and CXCR3+ T cells to convert 'cold' melanoma and drive durable regression. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41916730 | PubMed |
| 41673092 | Synergistic reprogramming of the tumor immune microenvironment by Senecavirus A and STING agonist. | Oncogene | 2026 | https://conductscience.org/library/papers/41673092 | PubMed |
| 40698086 | Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms. | Front Immunol | 2025 | https://conductscience.org/library/papers/40698086 | PubMed |
| 38709860 | In Vivo Delivery of Spherical and Cylindrical In Vitro Reconstituted Virus-like Particles Containing the Same Self-Amplifying mRNA. | Mol Pharm | 2024 | https://conductscience.org/library/papers/38709860 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL21 | 6366 | PubTator's text mining | https://conductscience.org/library/genes/6366 | NCBI Gene |
| CD3E | 916 | PubTator's text mining | https://conductscience.org/library/genes/916 | NCBI Gene |
| DLL3 | 10683 | PubTator's text mining | https://conductscience.org/library/genes/10683 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL12A | 3592 | PubTator's text mining | https://conductscience.org/library/genes/3592 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| TNFSF14 | 8740 | PubTator's text mining | https://conductscience.org/library/genes/8740 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36938543
GET https://conductscience.org/api/papers/v1/36938543/references?page=2